Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-0.09%||69.50||1.0%||$509.20m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.61%||205.06||1.9%||$451.31m|
|REGN||Regeneron Pharmaceuticals, Inc.||-1.60%||625.00||2.7%||$399.60m|
|SNSS||Sunesis Pharmaceuticals, Inc.||2.68%||4.21||0.7%||$294.29m|
|EXAS||EXACT Sciences Corp.||5.55%||80.84||18.0%||$141.11m|
|BMRN||BioMarin Pharmaceutical, Inc.||1.56%||84.24||4.2%||$134.04m|
PDL BioPharma, Inc. engages in intellectual property asset management, and patent portfolio and related assets investment activities. Intellectual Property Patents The company has been issued patents in the United States and elsewhere, covering the humanization of antibodies, which are referred to as its Queen et al. patents.The company was founded as a Delaware corporation in 1986 under the name Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006.